+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Measles Drug"

From
Rubella (German Measles) - Pipeline Review, H2 2020 - Product Thumbnail Image

Rubella (German Measles) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 45 Pages
  • Global
From
Measles - Pipeline Review, H2 2020 - Product Thumbnail Image

Measles - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 49 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Measles Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat and prevent measles, a highly contagious viral infection. Measles drugs are typically administered in the form of a vaccine, which helps to stimulate the body's immune system to fight the virus. Vaccines are typically given to children and adults who have not been previously vaccinated. In addition to vaccines, antiviral medications may be prescribed to treat measles in those who have already been infected. The Measles Drug market is highly competitive, with a number of companies offering products. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Johnson & Johnson. Show Less Read more